Anti-platelet therapy does not significantly reduce pain crises in sickle cell disease
Treatment with the antiplatelet agent prasugrel does not significantly reduce the rate of pain crises or severe lung complications in children with sickle cell disease, according to a report published in the New England Journal ...
Dec 8, 2015
0
12